{"schema_version":"secwatch.filing_event.v1","accession":"0001808665-24-000041","form_type":"8-K","ticker":"ASRT","cik":"0001808665","company_name":"Assertio Holdings, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.726338+00:00","generated_at":"2026-05-30T02:07:34.058882+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Assertio Q3 net sales $28.7M, adj EBITDA $5.3M; board adds Stark, loses Staple/Vacirca","bullets":["Q3 net product sales $28.7M vs $35.1M YoY; net loss $2.9M vs $279.5M loss (prior year impairment).","Rolvedon net sales $15.0M (stable vs $15.1M Q2); Indocin $5.7M (down from $6.9M Q2) on generic competition.","Adjusted EBITDA $5.3M (down from $12.9M YoY); adjusted EPS $0.03 vs $0.01 YoY.","Cash and short-term investments $88.6M; debt $40M (6.5% convertible notes, maturity 2027).","Board changes: Staple/Vacirca departed Nov 7; Mason appointed Chair; Stark (ex-Teva CLO) named independent director."],"urls":{"canonical":"https://secwatch.observer/filing/0001808665-24-000041","json":"https://secwatch.observer/filing/0001808665-24-000041.json","markdown":"https://secwatch.observer/filing/0001808665-24-000041.md","text":"https://secwatch.observer/filing/0001808665-24-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808665/000180866524000041/0001808665-24-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808665/000180866524000041/asrt-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:07:34.058882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0dae01a07d","claim":"Peter Staple retired as Director at Assertio Holdings, Inc..","evidence_excerpt":"On November 7, 2024, Peter Staple notified the Board of Directors (the “Board”) of the Company of his intent to retire as a member of the Board, effective November 7, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866524000041/0001808665-24-000041-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"220ebb1019","claim":"Jeffrey Vacirca retired as Director at Assertio Holdings, Inc..","evidence_excerpt":"On November 7, 2024, Jeffrey Vacirca also notified the Board of the Company of his intent to retire as a member of the Board and its committees, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866524000041/0001808665-24-000041-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c0260f813f","claim":"David Stark was appointed as Director at Assertio Holdings, Inc..","evidence_excerpt":"On November 7, 2024, the Board appointed David Stark to the Board, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1808665/000180866524000041/0001808665-24-000041-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}